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SISTEM PEMANTAUAN GLUKOSA DARAH BERASASKAN RFID DWI 
JALUR TERBENAM UNTUK INTERNET KEBENDAAN PERUBATAN 
ABSTRAK 
Maklumat kesihatan yang direkodkan secara manual boleh menyebabkan 
kesilapan seperti pengenalpasti pesakit dengan tidak tepat dan salah memadankan 
data pesakit yang boleh menjejaskan keselamatan pesakit dengan serius. Untuk 
mengurangkan risiko kesilapan kepada pesakit diabetes, satu reka bentuk sistem 
pemantauan glukosa darah tanpa wayar dengan pembenamam RFID dwi jalur untuk 
Internet Kebendaan Perubatan telah dibangunkan. Dengan menggunakan kaedah ini, 
RFID pasif membolehkan komunikasi jarak dekat untuk membaca nombor 
pengenalan pesakit dan RFID aktif memanjangkan komunikasi jarak jauh untuk 
merekod dan memantau data glukosa darah wayar melalui rangkaian berbilang hop. 
Kerja yang dibentangkan dalam tesis ini menyumbang terutamanya kepada sistem 
terbenam dan aplikasinya dalam penjagaan kesihatan untuk mengurangkan beban 
merekod, mengesan dan memantau data pesakit dengan membenamkan sensor 
glukosa darah, RFID pasif, RFID aktif, WSN, M2M dan IoMT ke dalam satu 
platform. Konsep reka bentuk baru diwujudkan untuk mekanisme pengecaman 
pesakit, di mana mekanisme itu dibenamkan ke dalam peranti sumber untuk 
meningkatkan keupayaan sistem menetapkan nombor pengenalan secara automatik 
kepada setiap pengukuran glukosa darah (mmol/L) semasa pemantauan berbilang 
pesakit. Selain itu, keputusan dari eksperimen yang dijalankan menunjukkan bahawa 
sistem yang dibangunkan menghasilkan prestasi keseluruhan yang lebih baik 
berbanding dengan system BGM Bluetooth dan sistem BGM konvensional dari segi 
masa rakaman terpendek dan keupayaan penghantaran semula data. Dalam analisis 
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kebolehpercayaan dengan menggunakan kaedah statistik ANOVA dan DOE, 
mengesahkan bahawa bilangan hop dan bilangan nod akhir memberikan kesan ketara 
kepada prestasi PDR CSMA/CA konvensional. Kedua-dua parameter ini 
kemudiannya diambil kira dalam persediaan eksperimen untuk menilai prestasi 
algoritma CSMA/CA yang dipertingkatkan (EN-CSMA/CA), yang menggunakan 
mekanisme interupsi luaran dan pendekatan berasaskan lapisan silang. PDR 
meningkat daripada 94% (CSMA/CA konvensional) kepada 99.33% (EN-
CSMA/CA), iaitu peningkatan 5.33%. Model PDR menganggarkan bahawa untuk 
senario terbaik dan paling teruk, peratusan PDR adalah 100.0% dan 51.67%, masing-
masing. Untuk mengoptimumkan penyusunan penghala bagi perlaksanaan sebenar 
sistem DRBGM di kemudahan kesihatan, model kehilangan laluan yang 
dibangunkan menganggarkan bahawa penghala harus diletakkan pada jarak 30 m 
antara satu sama lain, yang disepakati dengan hasil ujian yang menunjukkan 
kedudukan penghala harus ≤ 40 m untuk mencapai prestasi terbaik PDR. PDR 
meningkat daripada 94% (CSMA/CA konvensional) kepada 99.33% (EN-
CSMA/CA), peningkatan 5.33%. Model PDR menganggarkan bahawa untuk senario 
terbaik dan paling teruk, peratusan PDR adalah 100.0% dan 51.67%, masing-masing. 
Untuk mengoptimumkan penyusunan penghala bagi perlaksanaan sebenar sistem 
yang dibangunkan di kemudahan kesihatan, model kehilangan laluan yang 
dibangunkan menganggarkan bahawa penghala harus diletakkan pada jarak 30 m 
antara satu sama lain, yang disepakati dengan hasil ujian yang menunjukkan 
kedudukan penghala harus ≤ 40 m untuk mencapai prestasi terbaik PDR. 
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EMBEDDED DUAL BAND RFID BASED BLOOD GLUCOSE 
MONITORING SYSTEM FOR INTERNET OF MEDICAL THINGS 
ABSTRACT 
Manually recorded health information could lead to errors such as inaccurate 
patient identification and mismatch patient data that could seriously affect patient 
safety. In order to reduce the risks of error for patients with diabetes, a new design of 
wireless blood glucose monitoring system with the embedment of dual band RFID 
for Internet of Medical Things is being developed. Using this method, passive RFID 
allows short-range communication to read automatically the patient identification 
number and active RFID extends long-range communication for recording and 
monitoring blood glucose data through multi-hop WSN. The work presented in this 
thesis contributes mainly to the embedded system and its application in healthcare to 
reduce the burden of recording, tracing and monitoring the patient‘s data by 
embedding blood glucose sensor, passive RFID, active RFID, WSN, M2M and IoMT 
into a single platform. A new design concept is established for the patient 
identification mechanism, where the mechanism is embedded in the source device to 
enhance the ability of the system to automatically assign the identification number to 
each blood glucose measurement (mmol/L) during multiple patients monitoring. 
Additionally, the results from the experiments conducted showed that the developed 
system produced better overall performance compared to the Bluetooth BGM and 
conventional BGM system in terms of the shortest recording time and the ability to 
retransmit data. In the reliability analysis using ANOVA and DOE statistical 
methods, the result validates that the number of hop and number of end node 
significantly affects the PDR performance of conventional CSMA/CA. These two 
  xxiv   
parameters are then taken into account in experimental setup for performance 
evaluation of the enhanced CSMA/CA (EN-CSMA/CA) algorithm that uses an 
external interrupt mechanism and a cross layer approach. The PDR increased from 
94% (conventional CSMA/CA) to 99.33% (EN-CSMA/CA), an improvement of 
5.33%. The PDR model estimates that for the best and worst scenario, the percentage 
of PDR is 100.0% and 51.67%, respectively. To optimize the arrangement of routers 
for real implementation of the developed system in health facilities, the developed 
path loss model estimates that the router should be positioned at a distance of 30 m 
from each other, which agrees with the test results which indicate that the router 
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CHAPTER 1  
 
INTRODUCTION 
1.1 Background and Motivation 
Diabetes mellitus (DM) is a significant public health problem that is 
recognised globally. The World Health Organisation (WHO) estimates that by the 
year 2030, Malaysia will have around 2.48 million people with DM (IPH, 2011). 
Figure 1.1 illustrates the trends and projections of diabetes by the year 2020, showing 
that the prevalence of diabetes even in 2011, based on the National Health Morbidity 
Survey (NHMS), was higher compared to the projected prevalence of diabetes in 
NHMS 2006 (Ngah et al., 2017). 
 
Figure 1.1  Diabetes trends and projections by 2020 in Malaysia (Ngah et al., 
2017) 
 
NHMS 2015 revealed that most people with diabetes sought medical 
treatment at Ministry of Health (MOH) health clinics (59.3%), followed by MOH 
hospitals (20.0%), private clinics (15.1%) and private hospitals (3.6%) as illustrated 
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in Figure 1.2 (IPH, 2015). NHMS 2015 also estimated that the high population 
growth in Malaysia, if continued, will undoubtedly overload the nation‘s healthcare 
systems. Currently, the ratio of doctors to the population is 1:633 and the ratio of 
nurses to the population is 1:333 (Mei Kei, 2017).  
 
 
Figure 1.2 Common place of treatment for diabetic patients (IPH, 2015)  
 
 
The MOH has implemented a Total Hospital Information System (THIS) in 
order to improve the scheduling and day-to-management of surgical operations and 
services within the healthcare system. In utilising this system, diabetes health records 
should be recorded directly into the system electronically, and information and 
equipment tracked through using barcode identification tags and patient ID numbers. 
At present, nurses record blood glucose data on a piece of paper, and following the 
conclusion of their ward rounds, will enter the data into the hospital system at the 
nurses' station. In contrast, the proposed process as outlined in this study will provide 
a significant benefit concerning the reliability of blood glucose data compared to 
manually recorded information which may not be accurately entered and recorded 
into the system. For instance, data may become mixed up with other data during the 
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data entry and compiling process in the hospital system. Therefore, to improve the 
reliability and integrity of blood glucose data, the use of a wireless blood glucose 
monitoring (BGM) system will assist to automatically store data into THIS, thus 
minimising the occurrence of errors due to human intervention.  
Also important is the accurate identification of patients in the effective 
management of diabetes. From patient admission and throughout the range of care 
provided by the hospital, matching the correct patient name and personal details to 
the correct medication, specimen, test, and procedure are crucial to improving patient 
safety. In the conventional manual process to identify patients, mistakes can 
invariably occur which may seriously compromise the patient‘s safety and health 
condition, and preventing them from receiving proper treatment. 
The emergence of smart devices, Radio Frequency Identification (RFID), 
Wireless Sensor Network (WSN) and other communication technologies as shown in 
Figure 1.3 has led to the exponential growth of online applications associated with 
the Internet of Things (IoT). 
 
Figure 1.3 Technologies associated with the IoT (Xu et al., 2014) 
 
 
  4   
In fact, it has been projected that by the year 2025, healthcare applications 
will dominate the IoT as shown in Figure 1.4. In the modern health care 
environment, the application of IoT technologies has brought with it, the 
convenience for both medical professionals and patients, given these applications can 
be applied to various medical areas and procedures including real-time monitoring, 
patient information management, and healthcare management. Indeed, electronically 
connected medical devices will help to free up much-needed resources in clinics, 
alleviate and reduce stress and costs for those undergoing treatment, and will 





Figure 1.4 Projected market share of dominant IoT applications by 2025 (Al-
Fuqaha et al., 2015) 
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For indoor healthcare monitoring systems, several alternate technologies have 
been proposed including the use of Wi-Fi, RFID and Bluetooth. Mainetti et al. 
(2014) carried out a comparison among these technologies and concluded that RFID 
and Bluetooth technologies were the optimal solutions to reduce costs and providing 
less complexity in terms of hardware development and implementation. Blood 
glucose testing in hospitals and clinics involves a multitude of patients, covering a 
large area in monitoring patients simultaneously. The main concern in using a 
Bluetooth glucometer in a health facility for blood glucose monitoring is due to the 
limitation in transmitting data over long distances, inability to provide unique 
identification for multiple patients and compatibility with smartphone devices. 
Additionally, the pairing process of the Bluetooth glucometer requires a lengthy 
setup process, whereas RFID can provide an effective solution in overcoming the 
limitations of using Bluetooth technology. 
Embedding RFID and WSN technology in forming IoT components can 
contribute to remote and automated blood glucose monitoring in a health facility 
environment. Furthermore, the deployment of a diabetes monitoring system utilising 
the IoT platform will enable the system to be deployed anywhere. For remote 
monitoring, doctors can access data via an online diabetes management system for 
tracking the performance of patients‘ blood glucose levels which can assist doctors in 
diagnosing and providing treatment to patients. Therefore, there is a need to improve 
the BGM system by utilising RFID in a WSN platform and embedding the system 
with a mechanism to identify patients for crowd testing and regular usage. To the 
best of the researcher‘s knowledge, such a design of a wireless BGM system is the 
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1.2 Problem Statements 
In crowd blood glucose monitoring, the existing wireless BGM system does 
not have the ability to automatically attach a patient identification number to the 
blood glucose reading for each patient during the remote recording of data into an 
electronic health record system. To overcome the limitations, the proposed system 
requires wireless technology capable of managing wireless communication at both 
short and long ranges. The short-range is for collecting the identification number of 
the patient, while the long-range is for remote data recording. Nonetheless, the 
wireless technology cited in the literature for the existing blood glucose monitoring 
system operates in a single band, restricting system interoperability and functionality 
to manage short- and long-range application. Besides, the existing wireless BGM 
design is focused on self-monitoring instead of monitoring multiple patients in which 
a single device can be shared across multiple patients. For example,  the Bluetooth 
BGM system invented  by Simpson et al. (2010) and Ow-Wing (2015), the 
identification number of the patient is registered in the mobile application at the 
receiving device. Such design limits the BGM system in detecting the identification 
number of different patients, as it requires the removal of the previous patient‘s data 
by uninstalling the mobile application and reinstalling it. Moreover, data collection 
and data analyses are dependent on human‘s intervention to input the data.  
The main concerns regarding communication schemes for a BGM system in 
the WSN platform is regarding the ability to use the system remotely in real-time and 
to preserve the integrity of the monitoring data. Zigbee provides solution to data 
collision with the use of CSMA/CA mechanism. Due to its technical uniformity, 
highly scalability, the efficiency of CSMA/CA mechanism of ZigBee protocol will 
be affected in specific environments. In fact, collision rate and back off period are 
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still relatively high and long in star topology deployment even though the Zigbee 
network occupied only with fewer nodes (Singh, 2012). The development of the 
beacon-enabled mode (slotted CSMA/CA) protocol developed by Shu et al. (2015) 
and Di Francesco et al. (2011) is not feasible in accommodating the need for real-
time data processing in a multi-hop network as the nodes need to synchronise with 
the coordinator and listen to periodic beacons in order to the transmit data. In 
contrast, using an unslotted CSMA/CA mechanism, the nodes have no restriction in 
transmitting data at any time due to no alignment to a slot boundary. However, if all 
nodes attempt to transmit data simultaneously, data will collide which will jeopardise 
the integrity of collected data and affect the analysis of data for diagnosis and 
treatment of diabetic patients. The majority of work on the development of the 
unslotted CSMA/CA protocol has only considered simulation analysis, for example, 
the work developed by De Guglielmo et al. (2016) and Ur Rehman et al. (2014). 
These works also do not provide analysis on the multi-hop network given this 
information is vital for prediction efficiency in implementing the system in a large 
area of a health facility.  
 
1.3 Research Objectives 
The objectives of the research are as follows. 
i. To improve the design and functionalities of the wireless BGM system by 
embedding dual band RFID (passive and active RFID) into a single WSN 
platform by focusing on patient identification number assignment to the 
blood glucose reading for each patient during remote data recording into an 
electronic system in order for the system to be used in crowd monitoring with 
regular use in a large area of a health facility.  
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ii. To propose a new approach to enhance conventional unslotted CSMA/CA for 
preserving data integrity, to evaluate the performance of the proposed 
protocol and improve the reliability of real-time wireless blood glucose 
monitoring data. 
iii. To develop and construct a prototype of the proposed real-time wireless 
BGM system as a proof of concept for the implementation of the Internet of 
Medical Things. 
 
1.4 Research Scopes and Limitations 
The research work in this thesis focuses on two elements. First by defining 
the problem precisely and proposing solutions, and secondly, by producing 
meaningful results in order to achieve the objectives of this research.  
 The first element incorporates the process of designing and developing 
embedded dual-band RFID (passive and active) tags and the active RFID reader 
starting from designing the circuit diagrams, selection of the glucometer, passive 
reader, microcontroller, active components, design circuit schematic, the Printed 
Circuit Board (PCB) layout design and fabrication as well as installation of the 
components.  
The second element encompasses software development, which focuses on 
various functions for the microcontroller to communicate with the glucometer, 
passive reader, Zigbee module, external memory, in real-time as well as developing 
the GUI to interface with the RFID reader. The tag is designed not only to 
communicate with the glucometer and passive reader but also to achieve high data 
integrity of glucose information by embedding the enhancement anti-collision 
algorithm into the program coding. The raw data sent by the system tags contain 
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information such as the IEEE address, patient ID, glucose reading, time stamp, meal 
flags and patient comment. The developed system supports M2M communication 
that enables the active RFID reader to exchange real-time information with the 
embedded active RFID tags in a two-way communication channel to update the 
status of delivery and validate the data with minimal human intervention through 
utilising the IoT environment.  
All experiments are conducted in a real-world environment by assuming that 
the same environment is applied during blood screening of diabetic patients to ensure 
the research objectives are achieved. However, this work does not focus on the 
accuracy of the blood reading as the glucometer that is used in this research is a 
commercial device. Instead, the focus is towards system design, development, 
improvement, implementation, embedding technology and testing in order to achieve 
the objectives of this research from various perspectives. 
 
1.5 Research Contributions 
The contributions of this research are summarised as follows. 
i. New design architecture comprises of embedded blood glucose sensor, 
passive RFID, active RFID, WSN, M2M and IoMT in a single platform for 
real-time wireless blood glucose monitoring for healthcare facilities. This 
new embedded system enables short-range communication to read patient 
identification number and extend long-range communication via multi-hop 
network for remote blood glucose data recording into an electronic system.  A 
new design concept is established for a patient identification mechanism, 
where the mechanism is embedded into a source device. This enhances the 
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capability of the proposed system to be used for multiple patients, and each 
blood glucose measurement is automatically assigned to their identification 
number during blood glucose testing. These features allow easy tracking, 
monitoring and analysis. 
ii. Formulating new approaches and algorithm for performance enhancement 
unslotted CSMA/CA (EN-CSMA/CA) for preserving the integrity and 
improving the reliability of real-time monitoring data of the developed BGM 
system in large area of health facility. This is achieved by implementing a 
DOE approach and statistical analysis to verify the robustness of the system 
and performance and also considering multi-hop network factor analysis.  
iii. A new prototype system is developed and implemented as proof of concept in 
performing M2M communication for remote blood glucose monitoring. This 
embedded system is in the form of a portable wireless BGM system which is 
relatively easy to be set up in a health facility thereby allows more extensive 
wireless coverage in a multi-hop network. 
iv. Formulating a packet delivery ratio model for predicting the effects from the 
distance and interaction factors of a number of DRBGM tags * number of 
hops, for reliable implementation in large area of health facility. 
 
1.6 Thesis Outline 
The structure of this thesis is comprised of six chapters as described below. 
Chapter Two reviews the various methodologies and problems with the 
current wireless BGM system based on existing literature.  
Chapter Three describes the specifications and operation of the key 
components used in the research work in order to develop an active RFID system 
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embedded with a glucose meter and passive reader functionality with the aid of a 
WSN communication platform for indoor monitoring. This chapter also describes the 
hardware and software design, development and configuration of a complete 
embedded RFID system. 
In Chapter Four, the methodology used to setup the hardware, software and 
network design and development including the embedded mechanism between 
devices and WSN in the IoT is described. The schematics of the embedded RFID tag, 
reader and router are presented along with the communication algorithm 
implemented in the RFID tag and reader, respectively. All testing and results 
concerning the proposed embedded RFID system prototype are compared with the 
standalone RFID system and an RFID system embedded with sensors to evaluate and 
verify the capabilities of the proposed system. 
Chapter Five describes the findings and discusses the process of testing the 
wireless BGM system as a Proof of Concept (POC) in the selected real-world indoor 
environment. This chapter also details the actual contributions and advantages of the 
entire package of the proposed embedded RFID system by summarising the findings 
in the form of design specifications for the RFID tag and reader together with a 
comparison between the proposed embedded RFID system with prior approaches 
found in the literature. 
Chapter Six concludes the research by addressing the objectives of the 
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The chapter begins with an overview of diabetes mellitus and continues by 
highlighting the patient identification issues in healthcare. Discussion on the 
important aspects of Internet of Things (IoT) applications, RFID, WSN and Zigbee 
are next presented along with a comparison with other wireless technologies.  This 
chapter next examines the existing body of literature on the design of a wireless 
blood glucose monitoring (BGM) system and related works on patient identification 
technologies. Related to the event-driven application as implemented in the proposed 
system, the chapter examines the issue of IEEE 802.15.4 MAC by investigating the 
related works in addressing the issue. Design of experiment concept is discussed in 
the last section of this chapter. The flowchart of the literature review is summarised 




 Communication range for 















Diabetes monitoring issues 
in health facilities
 
Figure 2.1 Flowchart of the literature review 
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2.2 Overview of Diabetes Mellitus 
The Egyptians first mentioned diabetes mellitus around 1500 BCE. Diabetes 
mellitus (DM) is an incurable disease resulting from an insufficient amount of insulin 
in the human body, causing elevated blood glucose levels, known as hyperglycaemia, 
or reduced glucose concentrations, known as hypoglycaemia (Sabokdast et al., 
2015). Insulin is a hormone made by the pancreas in the body that regulates the 
amount of glucose in the blood.  
Diabetes is classified into type 1 diabetes, type 2 diabetes, and gestational 
diabetes. Type 1 diabetes occurs when no or very little insulin is released into the 
body due to the immune system mistakenly attacking and killing the beta cells of the 
pancreas. As a result, sugar builds up in the blood instead of being used as energy. 
Type 1 diabetes requires treatment with insulin. Whereas, type 2 diabetes occurs 
when the body cannot properly use the insulin that is released or does not make 
sufficient insulin. Similar to type 1, sugar builds up in the blood instead of being 
used as energy. Type 1 and type 2 diabetes have been associated with many medical 
complications including cardiovascular disease, neuropathy, nephropathy, 
retinopathy, foot damage, skin problems, hearing impairment and chronic depression. 
The third type of diabetes, gestational diabetes, is a temporary condition that occurs 
during pregnancy. Here, uncontrolled blood sugar levels in pregnancy can also cause 
the baby to grow too large, having a higher risk of developing obesity as well as 
causing death either before or shortly after birth. Additionally, the mother may also 
experience preeclampsia and subsequent gestational diabetes (Berger et al., 2016).  
Complications from diabetes have resulted in greater expenditure and reduced 
productivity, becoming a socio-economic concern (Huse et al, 1989; O‘Brien et al., 
1998). Moreover, monitoring glucose levels in the blood has been proven to prolong 
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life expectancy by enabling people with diabetes to manage episodes of hypo- or 
hyperglycaemia, therefore providing better control over their condition and by 
preventing some of the debilitating side effects (Makaram et al., 2014; Ferrante do 
Amaral & Wolf, 2008). 
The key part of diabetes management is in understanding blood glucose level 
ranges, which are checked using a blood glucose monitoring system. The blood sugar 
levels in diagnosing diabetes are shown in Table 2.1.  
 










Random Below 11.1 N/A 11.1 or more 
Fasting Below 5.5 5.5 to 6.9 7.0 or more 
2 hour post-
prandial 
Below 7.8 7.8 to 11.0 11.0 or more 
 
According to the results from the 2011 National Health & Morbidity Survey 
(NHMS), an estimated 1.1 million patients with diabetes received treatment at public 
health care facilities in Malaysia, with 70% of patients attending primary care clinics. 
Whereas, the remaining patients received treatment and follow-up at public hospitals 
(IPH, 2012). Notably, medical officers and physicians mostly deliver public hospital-
based diabetes care within general medicine outpatient clinics in the hospital 
(Hussein et al., 2015). 
On the other hand, glycaemic control for hospitalised patients with diabetes 
requires accurate near-patient glucose monitoring systems. During the last decade, 
point-of-care blood glucose monitoring devices have become the mainstay of near-
patient glucose monitoring in hospitals globally (Rajendran & Rayman, 2014), given 
that the blood glucose measurement result can be obtained in minutes compared to 
what could take hours employing laboratory tests. The Ministry of Health in 
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Malaysia has enforced the use of Total Hospital Information Systems (THIS) to 
record all health-related data, including blood glucose data into the system. However, 
the data entry of THIS is a manual process, which is susceptible to human errors. The 
technical performance of conventional blood glucose monitoring (BGM) system is 
tabulated in Table 2.2. Therefore enhancing the functionality and capability of the 
BGM system could positively affect the level of work involved and enhance patient 
care across the public health care facilities. 
 
Table 2.2 Technical performance of conventional blood glucose monitoring 
system 
System Conventional BGM System 
Method to record data to database system Manual data entry 
User identification mechanism Visual check the Patent ID 
Card 
Type of blood glucose data collection  Non-real-time 
Number of patient per system setup One patient 
Diabetes Management Software NA 
2.2.1 Patient Identification Issues in Healthcare 
A blood glucose reading without knowing the identification of a patient is 
meaningless. Patient identification refers to the process of assigning a unique 
identification ID to a patient. Patient identification is one of the most important 
elements of patient safety by identifying each patient precisely and correctly 
matching their data to facilitate the best possible decisions about treatment and 
diagnosis (Morris, 2014). The Joint Commission for Accreditation of Health Care 
Organizations (2016) recommends the use of at least two identifiers (e.g., the 
patient’s name and their date of birth) to verify a patient’s identity. In the health 
facilities in Malaysia, the inpatients are identified based on the presence of the ID 
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band that contains information on  the patient‘s full name, medical record number 
and date of birth whereas, outpatients are identified through their National ID and are 
confirmed with details contained in their medical record.  
However, there is significant evidence that errors in the identification of 
patients do occur in health services. The misidentification of patients has been 
disclosed as the root cause for the majority of medical errors including specimen 
misidentification (Upreti et al., 2013), adverse drug events (Fyhr & Akselsson, 2012) 
and incorrect blood transfusion (Cottrell et al., 2013), which can cause the loss of a 
patient‘s life. In the root cause analyses study, Dunn and Moga (2010) found that 
9.48% out of 182 patient ID errors in the medical results from the post-analytic phase 
were recorded into the wrong patient medical record. While, the study conducted at 
the Endocrinology-Diabetology-Nutrition Department at Montpellier Hospital, 
France revealed that patients with diabetes had more serious medication errors at the 
hospital compared to non-diabetic patients (Breuker et al., 2017). Medication errors 
can be lethal, with the estimated death of more than 7,000 patients each year from 
preventable errors (Walsh, 2015). In Malaysia, the figures in 2010/2011 NHSLA 
Annual Report and Accounts reveals that  the number of clinical negligence claims 
reported in 2010/11 was 8655, which represents a 30% increase over 2009/10 (6652) 
(Hambali & Khodapanahandeh, 2014). 
 
2.3 Internet of Things Applications and Benefits 
The IoT comprises a network of electronic physical devices that are 
interconnected, exchange data and interacts with each other beyond machine-to-
machine (M2M) communication. Multiple technologies are involved in the IoT, with 
one solution in managing all communications. This ingenious evolution has attracted 
 
  17   
the interest and attention of many industries to be part of the IoT such as information, 
transportation, agricultural, healthcare and manufacturing industries as shown in 
Figure 2.2. In balancing the demand and supply in healthcare services, the growth of 
the IoT continues to grow and proliferate. The capability of medical devices and 
application systems to interact and share data through online computer networks 




Figure 2.2 Investments in IoT solutions by industry (Newman, 2019) 
 
In other spectrums, the industrial revolution aimed at creating intelligent 
factories by applying advanced technologies including the IoT and cloud computing 
is known as Industry 4.0 (Lee et al., 2015). In the context of the healthcare system, 
the term Industry 4.0 is used to represent an in-depth change in the way healthcare 
services are provided and how information, technology and processes integrate 
forming a lean healthcare system. Lean healthcare is a set of operating philosophies 
and methods that help to create maximum value for patients by reducing waste and 
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waiting time (Lawal et al., 2014). Hence, integrating Industry 4.0 in the healthcare 
system is important given the benefits of improving access to care, reducing 
healthcare costs and most importantly increasing patients‘ quality of life. This 
transformation can be realised through utilising and taking advantage of the IoT. 
Innovative technologies like ZigBee, WSN, RFID, smart sensors, distributed 
databases and energy saving technologies, associated with IoT, have huge potential 
in remote healthcare monitoring systems and medical services to improve patient 
safety, healthcare services and also to reshape the future of the healthcare industry. 
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Given the benefit afforded by IoT infrastructure, many researchers have 
shown significant interest in adopting IoT in their applications. Table 2.3 shows 
some of the related work in healthcare applications that have adopted the IoT 
concept.  
 
Table 2.3 Healthcare applications using IoT 
Authors Application Benefit 




High accuracy detection and 
easy to use 
Chandel et al. (2016) Continuous 
monitoring for 
step count, stride 
length, fall and 
calorie 
Trigger an automatic alarm for 
the need of an urgent attention 
to the elderly subject, real-time 
feedback on step count and 
distance , accurate calories 
estimate 
Puri et al. (2016) Cardiac 
Arrhythmia 
Management 
enable an inexpensive auto-
triggered arrhythmia cardiac 
management solution catering 
the need of in-house, round-
the-clock cardiac health 
monitoring 
 
2.4 Radio Frequency Identification (RFID) 
The concept of RFID was initially discovered during World War II (Landt 
,2005) which has since evolved. RFID provides a feasible solution to all tracking 
applications using an identification mechanism via radio waves. The frequency 
ranges of RFID based on the international standards range from 135 kHz to 2.4 GHz. 
The characteristics of RFID operating frequencies are described in Table 2.4. RFID 
can be categorized into passive and active which are embedded for short and long 
range communication, respectively, in the proposed system. Details of these RFIDs 
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2.4.1 Passive RFID 
A basic configuration of a passive RFID system consists of a reader, passive 
tag, and application computer (Tashi et al., 2011) as illustrated in Figure 2.4. The 
type of RFID system depends on the type of utilised tag. A passive tag does not have 
a battery, and vice versa for an active tag. The passive tag obtains all the energy from 
the generated RF field and then backscatters the signal to the RFID reader (Chawla 
& Ha, 2007). The backscatter signal contains data in the form of an identification 
string, which is pre-stored in the internal memory of the passive tag. 
 
 
Figure 2.4 Passive RFID system (Tashi et al., 2011) 
 
In the majority of cases, the read range of the passive RFID system is limited 
given the low sensitivity of the passive tag which requires a strong RF signal from 
the reader (Koelle et al., 1975). Conventional passive RFID tags are limited in their 
capability; however, the tags have an indefinite operational life and are sufficiently 
tiny enough to fit into a practical adhesive label (Want, 2006).  
The passive RFID systems can be operated in low frequency (LF), high 
frequency (HF), and ultra-high frequency (UHF) bands. However, there are currently 
no commercially available passive RFID ICs for 2.4 GHz (Nikitin, 2019). Numerous 
communication protocols exist for RFID systems as shown in Table 2.5. The 
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standards and guidelines for the interactions between the passive tags and the readers 
are based on the Electronic Product Code (EPC) global specifications (GS1, 2015) 
and International Organization for Standardization (ISO) 18000-6 (ISO, 2013), 
which are adopted by industry in the Ultra High Frequency (UHF) passive RFID 
field. The first generation of the RFID was named as Generation 1 (Gen 1) and the 
second generation (Gen 2) of the RFID UHF tags were then developed to establish a 
standard for RFID tags, operating frequency band and offer a longer operational 
range (Coca & Popa, 2011). Table 2.5 displays details of the improvements in Gen 2 
in comparison to the Gen 1 protocol.  
 
 
Table 2.5 Comparison between Gen 1 and Gen 2 (Coca & Popa, 2011) 
Description Gen 1 Gen 2 
Acceptance level Not a global standard ISO-UHF 18000-6 
standard 
Arbitration Deterministic binary tree 
for Class 0 and 





Binary tree algorithm with 
persistent state/wake 
states 
Q algorithm, which is a 
variant of the slotted 
aloha protocol 
Air interface Pulse width modulation 
(PWM) for Class 0 and 
Class 1 
Pulse interval encoding 
(PIE−ASK), Miller, FM0 
Data rate 40/80 Kbits for Class 0 
and 
70/140 bits for Class 1 
40 to 640 Kbits 
Distance Less than 10 meters Less than 10 meters 
Frequency range 850–930 MHz 860 to 960 MHz 
Security password 8 and 24−bit passwords, 
respectively, for Class 1 
and Class 0 
32 bits 
Data write verification No  Yes 
Write speed (for 96−bit 
electronic product code) 
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Gen 2 protocol provides great versatility in properties of physical layers and 
linking layer procedures to suit different conditions (Zhang et al., 2009). Gen 2 
standard specifies the communication between the reader and the tag regardless of 
the particular frequency range within which the system operates, thereby providing 
developers with basic blueprint detailing how the system (readers and tags) should 
communicate. It also provides a robust mechanism, the EPC number, for unique ID 
which can handle the need for the trillions of unique IDs required by healthcare 
sector. The Gen 2 frequency range is between 860 and 960 MHz and it covers all 
international frequency spectrums. Factors such as interoperability of Gen 2, short 
reading range and small tag size fulfil the requirement that the proposed passive 
RFID operates within this frequency range. 
 
2.4.2 Active RFID 
Given the availability of an internal power source, the sensors can be 
embedded into the active tag in order to extend the capability of the RFID system for 
tracking and monitoring applications. For instance, the vibration sensor is embedded 
into an active RFID system for asset monitoring (Hamid et al., 2013) as 
demonstrated in the architecture design of an active tag in Figure 2.5.  
 
  24   
 
Figure 2.5 Architecture of an active RFID tag (Hamid et al., 2013) 
 
In addition to that, the capability of the active tag to establish communication 
with the reader enables the RFID system to be actively deployed in real-time 
applications such as those that are event-driven and for periodic monitoring in the 
healthcare system. Table 2.6 displays the capability of an active RFID system in 
comparison to a passive RFID system (Cisco, 2008). 
 
Table 2.6 Active RFID versus passive RFID (Cisco, 2008) 
 
Characteristics Passive RFID Active RFID 
Tag power source Energy transferred from the 
reader via RF 
 
Internal to tag 
Tag battery No Yes  
Availability of tag 
power 
Only within field of reader Continuous 
Required signal 
strength from reader 
to tag 
Very high Very low 
Communication 
Range 
Short-range (3m or less) Long-range, more than 100 
m depends on types  
Sensor capability Read and transfer sensor 
data only when tag is power 
by reader without date/time 
stamp 
Continuously monitor and 
record sensor input with 
date/time stamp 
Data storage Small (typically 128 bits) Large (128kB or larger) 
